Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation
about
MUC1-C activates BMI1 in human cancer cells.Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition.MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors.Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas.MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.MUC1-C activates EZH2 expression and function in human cancer cells.Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective Breast Cancer Detection in a Mucin-1 Transgenic Murine Mouse Model.MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer.MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.Systemic delivery of the tumor necrosis factor gene to tumors by a novel dual DNA-nanocomplex in a nanoparticle system.MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer.
P2860
Q33704573-B8B6248A-12A6-4594-AFD3-780955F27FC4Q36693297-F9404B40-0C58-4EA4-A4D7-3F942A099F02Q36821095-E17BB1C5-5C42-4A6A-91A3-48310C01EF78Q36928457-13E131AC-60E3-43F9-8FDA-DE60415BB574Q37022006-2A05854D-C8D7-49D9-B8FC-7DE4D7AF0CDBQ38660089-45280D63-3FDB-450F-8D6F-D8AF171084A9Q38744303-01314E5B-4696-4BD2-869E-9EFDF476CD3BQ39182659-EB019E03-6CB5-4A3B-B53C-63EF282CD9D8Q41008660-49B7306F-FF97-40D1-84F0-D39A8364F480Q41286875-DEEF2FF8-1944-4944-9D95-3909D4F3B5E4Q47759359-AF7F4580-41B2-4526-8BC4-FCAEFA5EE7C5Q47951334-0318FA57-F7FF-4C6D-9F1F-2BD799C652D1Q48146766-29D3ACD0-2915-431A-89D4-A4FE24CFF51AQ50945439-FD9787D5-D49A-4B78-8618-5B5E49CB9CC6Q52742033-3B13D6C2-9BA3-4396-8C2F-EF0BE40094CE
P2860
Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Intracellular Targeting of the ...... O-203 Nanoparticle Formulation
@ast
Intracellular Targeting of the ...... O-203 Nanoparticle Formulation
@en
Intracellular Targeting of the ...... O-203 Nanoparticle Formulation
@nl
type
label
Intracellular Targeting of the ...... O-203 Nanoparticle Formulation
@ast
Intracellular Targeting of the ...... O-203 Nanoparticle Formulation
@en
Intracellular Targeting of the ...... O-203 Nanoparticle Formulation
@nl
prefLabel
Intracellular Targeting of the ...... O-203 Nanoparticle Formulation
@ast
Intracellular Targeting of the ...... O-203 Nanoparticle Formulation
@en
Intracellular Targeting of the ...... O-203 Nanoparticle Formulation
@nl
P2093
P2860
P3181
P1476
Intracellular Targeting of the ...... O-203 Nanoparticle Formulation
@en
P2093
Akriti Kharbanda
Deepak Raina
Dikshi Gupta
Donald Kufe
Govind Panchamoorthy
Harpal Singh
Manoj Kumar
Maroof Alam
Masanori Hasegawa
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-14-3000
P407
P577
2015-05-15T00:00:00Z